(Q40210045)

English

Efficacy and tolerability of moxifloxacin in patients with sinusitis treated in general practice : results of a post-marketing surveillance study

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Efficacy and tolerability of moxifloxacin in patients with sinusitis treated in general practice : results of a post-marketing surveillance study (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

based on heuristic

inferred from title

author name string

Elies W

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Landen H

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Stauch K

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

431-439

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Evaluation of the clinical microbiology profile of moxifloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of prescription patterns in general practice on anti-microbial resistance in Norway

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious etiology of acute exacerbations of chronic bronchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute community-acquired sinusitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAY 12-8039, a novel fluoroquinolone. Activity against important respiratory tract pathogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin in the Treatment of Acute Maxillary Sinusitis after First-Line Treatment Failure and Acute Sinusitis with High Risk of Complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious rhinosinusitis in adults: classification, etiology and management. International Rhinosinusitis Advisory Board

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving care for patients with respiratory tract infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A critical review of the fluoroquinolones: focus on respiratory infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of Bay 12-8039, a new 8-methoxyquinolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute exacerbations of chronic bronchitis: an international comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetration of moxifloxacin into peripheral compartments in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523703

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200424080-00001

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40210045&oldid=1888742476"